Hcw biologics to participate in h.c. wainwright bioconnect conference january 10 – 13, 2022

Miramar, fla., jan. 06, 2022 (globe newswire) -- hcw biologics inc. (the “company”) (nasdaq: hcwb), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases, announced today that members of the hcw biologics management team will participate in the h.c. wainwright bioconnect conference. the event is taking place january 10 – 13, 2022.
HCWB Ratings Summary
HCWB Quant Ranking